Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation
Title:
Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation
Author:
Katz, Matthew H. G. Varadhachary, Gauri R. Fleming, Jason B. Wolff, Robert A. Lee, Jeffrey E. Pisters, Peter W. T. Vauthey, Jean-Nicolas Abdalla, Eddie K. Sun, Charlotte C. Wang, Huamin Crane, Christopher H. Lee, Jeffrey H. Tamm, Eric P. Abbruzzese, James L. Evans, Douglas B.